Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Theiler

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Biorxiv : the Preprint Server for Biology|February 3, 2021
SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral Spike vaccinesXiaoying Shen, Haili Tang, Charlene McDanal, et al.
Plos One|May 30, 2009
Quantitative deep sequencing reveals dynamic HIV-1 escape and large population shifts during CCR5 antagonist therapy in vivoAthe M N Tsibris, Bette Korber, Ramy Arnaout, et al.
The Lancet Regional Health. Western Pacific|May 16, 2023
Efficacy of antivirals and mRNA vaccination against an XBF clinical isolateRyuta Uraki, Mutsumi Ito, Maki Kiso, et al.
Vaccine|October 23, 2023
Neutralization escape by SARS-CoV-2 Omicron subvariant BA.2.86Ninaad Lasrado, Ai-Ris Y Collier, Nicole P Hachmann, et al.
Nature Medicine|February 23, 2010
Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeysSampa Santra, Hua-Xin Liao, Ruijin Zhang, et al.
Molecular Microbiology|January 15, 2014
Fitness costs of rifampicin resistance in Mycobacterium tuberculosis are amplified under conditions of nutrient starvation and compensated by mutation in the β' subunit of RNA polymeraseTaeksun Song, Yumi Park, Isdore Chola Shamputa, et al.
Nature Communications|March 24, 2023
Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolatesRyuta Uraki, Shun Iida, Peter J Halfmann, et al.
Cell|July 23, 2020
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 VirusBette Korber, Will M Fischer, Sandrasegaram Gnanakaran, et al.
Science Translational Medicine|May 17, 2022
Characterization of the SARS-CoV-2 B.1.621 (Mu) variantPeter J Halfmann, Makoto Kuroda, Tammy Armbrust, et al.
Science (New York, N.Y.)|October 20, 2022
Multiple lineages of monkeypox virus detected in the United States, 2021-2022Crystal M Gigante, Bette Korber, Matthew H Seabolt, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Biorxiv : the Preprint Server for Biology|February 3, 2021
SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral Spike vaccinesXiaoying Shen, Haili Tang, Charlene McDanal, et al.
Plos One|May 30, 2009
Quantitative deep sequencing reveals dynamic HIV-1 escape and large population shifts during CCR5 antagonist therapy in vivoAthe M N Tsibris, Bette Korber, Ramy Arnaout, et al.
The Lancet Regional Health. Western Pacific|May 16, 2023
Efficacy of antivirals and mRNA vaccination against an XBF clinical isolateRyuta Uraki, Mutsumi Ito, Maki Kiso, et al.
Vaccine|October 23, 2023
Neutralization escape by SARS-CoV-2 Omicron subvariant BA.2.86Ninaad Lasrado, Ai-Ris Y Collier, Nicole P Hachmann, et al.
Nature Medicine|February 23, 2010
Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeysSampa Santra, Hua-Xin Liao, Ruijin Zhang, et al.
Molecular Microbiology|January 15, 2014
Fitness costs of rifampicin resistance in Mycobacterium tuberculosis are amplified under conditions of nutrient starvation and compensated by mutation in the β' subunit of RNA polymeraseTaeksun Song, Yumi Park, Isdore Chola Shamputa, et al.
Nature Communications|March 24, 2023
Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolatesRyuta Uraki, Shun Iida, Peter J Halfmann, et al.
Cell|July 23, 2020
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 VirusBette Korber, Will M Fischer, Sandrasegaram Gnanakaran, et al.
Science Translational Medicine|May 17, 2022
Characterization of the SARS-CoV-2 B.1.621 (Mu) variantPeter J Halfmann, Makoto Kuroda, Tammy Armbrust, et al.
Science (New York, N.Y.)|October 20, 2022
Multiple lineages of monkeypox virus detected in the United States, 2021-2022Crystal M Gigante, Bette Korber, Matthew H Seabolt, et al.
Pageof 5